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Abstract
We constructed a 400K WG tiling oligoarray for the horse and applied it for the discovery of copy number variations (CNVs)
in 38 normal horses of 16 diverse breeds, and the Przewalski horse. Probes on the array represented 18,763 autosomal and
X-linked genes, and intergenic, sub-telomeric and chrY sequences. We identified 258 CNV regions (CNVRs) across all
autosomes, chrX and chrUn, but not in chrY. CNVs comprised 1.3% of the horse genome with chr12 being most enriched.
American Miniature horses had the highest and American Quarter Horses the lowest number of CNVs in relation to
Thoroughbred reference. The Przewalski horse was similar to native ponies and draft breeds. The majority of CNVRs involved
genes, while 20% were located in intergenic regions. Similar to previous studies in horses and other mammals, molecular
functions of CNV-associated genes were predominantly in sensory perception, immunity and reproduction. The findings
were integrated with previous studies to generate a composite genome-wide dataset of 1476 CNVRs. Of these, 301 CNVRs
were shared between studies, while 1174 were novel and require further validation. Integrated data revealed that to date,
41 out of over 400 breeds of the domestic horse have been analyzed for CNVs, of which 11 new breeds were added in this
study. Finally, the composite CNV dataset was applied in a pilot study for the discovery of CNVs in 6 horses with XY
disorders of sexual development. A homozygous deletion involving AKR1C gene cluster in chr29 in two affected horses was
considered possibly causative because of the known role of AKR1C genes in testicular androgen synthesis and sexual
development. While the findings improve and integrate the knowledge of CNVs in horses, they also show that for effective
discovery of variants of biomedical importance, more breeds and individuals need to be analyzed using comparable
methodological approaches.
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Introduction
The significance of gene duplication in long-term evolu-
tionary changes was already recognized over 40 years ago by
Susumu Ohno [1]. Yet, systematic genome-wide discovery and
functional interpretation of inter- and intraspecific copy
number variations (CNVs) in genes and non-genic DNA
sequences, started in the past decade with foundational studies
in humans [2,3] and mice [4], followed by genome-wide (GW)
CNV discovery in chicken [5], cattle [6], dogs [7,8] and other
domestic species (see [9,10]). It is now well established that
CNVs are a common feature of vertebrate genomes. Typically,
they are DNA sequence variants from at least 50 base-pairs
(bp) to over several megabase-pairs (Mb) in size that are
involved in deletions, insertions, duplications and transloca-
tions, causing structural differences between genomes [11,12].
In terms of the total number of DNA base-pairs, CNVs are
responsible for more heritable sequence differences (0.5–1%)
between individuals than SNPs (0.1%) [11,12,13].
One of the central goals of CNV research has been determining
their association with genome instability, genetic diseases and
congenital disorders. It is thought that CNVs, as a major source of
inter-individual genetic variation, could explain variable pene-
trance of Mendelian and polygenic diseases, and variation in the
phenotypic expression of complex traits [14,15]. Indeed, CNVs
have been associated with common complex and polygenic
disorders in humans affecting a broad range of biological
processes, such as immune response, autoimmunity and inflam-
mation [3,16,17]; musculoskeletal [18,19] and cardiovascular
systems [20,21]; neurodevelopment, cognition and behavior
[22,23], and sexual development and reproduction
[24,25,26,27,28].
The availability of whole genome (WG) sequence draft
assemblies combined with the advances in array-based technolo-
gies and next generation sequencing (NGS), have prompted CNV
research in all main domestic animal species (reviewed by [9,10])
with the most advanced information currently available for cattle
[6,29,30], pigs [31], and dogs [32,33,34].
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In horses, five studies report about the discovery of CNVs in the
whole genome [35,36,37,38] or in gene exons [39]. Attempts have
also been made to associate CNVs with equine diseases [36],
adaptations [38] and phenotypic traits [37,39]. While these studies
set a foundation for understanding the role of CNVs in equine
biology, the current information is inadequate for efficient
discovery of variants affecting equine health and disorders. This
is because the studies have used different CNV discovery
platforms, the number of breeds and individuals in some studies
is very limited, and the majority of reported CNVs are study-
specific and not validated by two or more independent studies.
Also, the available information has not been integrated into a
composite dataset to facilitate the analysis of known CNVs and the
discovery of new ones.
The aim of this study is to improve the current rather limited
knowledge of CNVs in horses by their genome-wide discovery in
multiple individuals of additional diverse horse breeds. Using a
custom-made WG tiling array we generate a CNV map for the
horse genome and integrate this with the previous CNV studies
into a composite dataset. Finally, we carry out a pilot CNV
analysis in horses with disorders of sexual development to test the
utility of the array and the integrated dataset for the discovery of
variants involved in equine complex disorders.
Results
The Texas-Adelaide horse whole-genome tiling array
Texas A&M University (USA) and The University of Adelaide
(Australia) collaborated to create a whole-genome (WG) 400K
tiling array which was produced and printed by Agilent
Technologies (Design ID #030025), and designated as the
Texas-Adelaide array. The probes on the array represented
18,763 autosomal and X-linked genes, and intergenic, sub-
telomeric and chrY sequences. Median genomic distance between
the probes on the array was 7.5 kb; this distance was lower (4 kb)
in sub-telomeric regions, and higher (,20 kb) in the Y chromo-
some. Before using the array for CNV discovery in horses, the
platform was tested for performance quality. Self-to-self control
hybridizations (Figure S1a) showed 1.55% of False Discovery Rate
(FDR) - an indication that the array design, fabrication, and array
genomic hybridization (aCGH) procedures were optimal. As a
proof-of principle, female-to-male hybridizations between two
half-sib Thoroughbreds, Twilight (female) and Bravo (male),
showed massive loss in the X chromosome and a gain in the Y
chromosome in the male, whereas only one CNV was detected in
an autosome, chr3 (Figure S1b). Hybridization quality was
assessed by measuring Derivative Log Ratio Standard Deviation
(DLRSD) which calculates probe-to probe log ratio noise and is
typically,0.3 for good quality hybridizations. The DLRSD values
for all hybridizations with blood DNA from Twilight and Bravo
were ,0.2. Therefore, and because the oligonucleotides on the
array were derived from the sequences of these two horses, DNA
of Twilight and Bravo was used as a reference for all aCGH
experiments: Twilight for females and Bravo for males. Further,
because our DNA collection from horse breeds contained samples
isolated from blood and hair, an additional self-to-self hybridiza-
tion was conducted using DNA from blood and hair of one male
Quarter Horse QH3-H528 (Table S1). Blood DNA gave good
quality results with DLRSD =0.14, whereas consistent and high
level hybridization noise was observed for hair DNA (DLRSD
=0.41) (Figure S1c). Due to this, CNVs in all samples were called
with stringent criteria: log2 ratio alterations higher than 0.5 over 5
neighboring probes – a necessary compromise between calling
CNVs with confidence and missing a few true calls. With median
probe spacing of 7.5 kb on the array, this allowed detection CNVs
of about 30 kb, and in probe-dense regions even smaller. We
concluded that the performance of the equine 400K Texas-
Adelaide whole-genome CGH array was optimal for the discovery
of CNVs in the horse genome.
CNV discovery and construction of a whole-genome CNV
map for the horse
The aCGH data are available at NCBI GEO accession
GSE55266. Collectively, 950 CNV calls were made across 36
horses, with an average of 26.4 calls per individual (Table 1; Table
S3). The number of CNV calls was the highest in two American
Miniature Horses (59 and 46) and the lowest in American Quarter
Horses (12 and 14), whereas the number of calls per individual was
not significantly different between blood and hair DNA (P=0.07;
Table 1) at the settings of log260.5 over 5 probes. The number
and distribution of CNVRs in the two Przewalski horses were
similar to those in domestic horses (Table 1, Table S4). Because
the Thoroughbred served as a reference, by default all the 950
CNV calls recorded in other breeds were also present in the
Thoroughbred, though inversely with respect to gains and losses.
However, because the Thoroughbred was compared with multiple
individuals, the same CNV had different log2 values, and that is
why the Thoroughbreds were not included in the comparisons of
CNV metrics.
The ADM-2 algorithm arranged adjacent and overlapping
CNV calls (CNVs) within and between individual horses into 258
CNV regions (CNVRs; Table S5) of which 114 were shared
between at least 2 individuals of the same or different breeds, while
144 were private and found only in one individual. Two CNVRs
were found in two or more individuals of the same breed but not in
other breeds and were tentatively considered as breed-specific: a
14 kb loss in chr9 in Exmoor ponies, and a 39 kb loss in chr20 in
Swiss Warmblood horses (Table S4).
Based on the 258 CNVRs, a whole genome CNV map for the
horse was constructed (Figure 1) details of which are summarized
in Table 2. The mean size of CNVRs was 110 kb ranging from
1 kb to 2.5 Mb. The CNVRs occupied 1.15 % of the equine
Author Summary
Genomes of individuals in a species vary in many ways,
one of which is DNA copy number variation (CNV). This
includes deletions, duplications, and complex rearrange-
ments typically larger than 50 base-pairs. CNVs are part of
normal genetic variation contributing to phenotypic
diversity but can also be pathogenic and associated with
diseases and disorders. In order to distinguish between the
two, detailed knowledge about CNVs in the species of
interest is needed. Here we studied the genomes of 38
normal horses of 16 diverse breeds, and identified 258 CNV
regions. We integrated our findings with previously
published horse CNVs and generated a composite dataset
of ,1400 CNVRs. Despite this large number, our analysis
shows that CNV research in horses needs further
improvement because the current data are based on
10% of horse breeds and that most CNVRs are study-
specific and require validation. Finally, we analyzed CNVs
in horses with disorders of sexual development and found
in two male pseudo-hermaphrodites a large deletion
disrupting a group of genes involved in sex hormone
metabolism and sexual differentiation. The findings
underline the possible role of CNVs in complex disorders
such as development and reproduction.
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genome and were distributed over all horse chromosomes, except
the Y, with the highest enrichment in chromosomes 12 (9.7%) and
20 (3.0 %). Even though chr12 is the gene richest chromosome in
the horse genome (15 genes/Mb), there was no overall correlation
between CNV enrichment and gene density. For example, the
enrichment values for the second and third gene densest
chromosomes, chr11 and chr13, were 0.02% and 0.28%,
respectively (Table 2). Likewise, we did not observe CNV
enrichment in sub-telomeres, as previously reported for humans
[40]: the array contained 5,716 sub-telomeric probes, though only
10 CNVRs were detected in these regions in horses.
In general, losses (173; 67%) prevailed over gains (63; 24%),
although 6 horses had more gains than losses (Table 1). Twenty-
two CNVRs (8.5%) were complex involving both losses and gains
in different individuals (Table 2, Table S3). Even though aCGH
on diploid samples cannot discriminate between copies of alleles
Table 1. Breed- and individual-wise summary of CNV calls in horses.
Horse breed Source of DNA for aCGH CNV calls per individual Gains Losses
Akhal-teke 1 Blood 37 12 25
Akhal-teke 2 Blood 26 13 13
American Miniature Horse 1 Blood 59 16 43
American Miniature Horse 2 Hair 46 4 42
American Quarter Horse 1 Blood 12 0 12
American Quarter Horse 2 Blood 21 2 19
American Quarter Horse 3 Blood 14 10 4
Arabian 1 Blood 21 17 4
Arabian 2 Hair 17 0 17
Belgian 1 Blood 31 14 17
Belgian 2 Hair 14 1 13
Caspian Pony 1 Blood 40 16 24
Caspian Pony 2 Hair 12 1 11
Clydesdale 1 Blood 25 6 19
Clydesdale 2 Hair 16 1 15
Exmoor Pony 1 Blood 29 15 14
Exmoor Pony 2 Hair 18 8 10
Fell Pony 1 Blood 25 11 14
Fell Pony 2 Hair 47 11 36
Friesian 1 Blood 29 6 23
Friesian 2 Blood 39 10 29
Friesian 3 Blood 41 9 32
Friesian 4 Blood 22 12 10
Mongolian Native Horse1 Hair 22 1 21
Mongolian Native Horse2 Hair 18 2 16
Percheron 1 Blood 17 11 6
Percheron 2 Hair 12 1 11
Przewalski’s Horse 1 Fibroblasts 21 5 16
Przewalski’s Horse 2 Fibroblasts 21 3 18
Sorraia 1 Blood 36 8 28
Sorraia 2 Hair 18 1 17
Standardbred 1 Blood 17 7 10
Standardbred 2 Blood 44 13 31
Swiss Warmblood 1 Blood 23 1 22
Swiss Warmblood 2 Blood 30 6 24
Swiss Warmblood 3 Blood 29 9 20
Thoroughbred 1 Blood Male reference n/a n/a
Thoroughbred 2 Blood Female reference n/a n/a
Average 26.4 7.3 19.1
Median 22.5 7.5 17.0
The number of calls per individual was not significantly different (Student’s T-test p= 0.07) between hair and blood DNA.
doi:10.1371/journal.pgen.1004712.t001
CNVs in Equine Health and Congenital Disorders
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Figure 1. A CNVR map of the horse genome. Green line – loss; red line – gain; yellow line – complex; black dots – genes involved.
doi:10.1371/journal.pgen.1004712.g001
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and thus, distinguish between heterozygous and homozygous
CNVs, two gains and 14 losses were tentatively considered
homozygous because of log2 alterations over 2.0 (Table S6).
Homozygosity of 8 losses was confirmed by qualitative PCR (Fig.
S2).
Gene content of CNVRs and functional categories of copy
number variable genes
The majority (82%) of horse CNVRs contained one or more
known Ensembl (http://www.ensembl.org/index.html) horse
genes (158 CNVRs) or non-horse mammalian reference genes
(54 CNVRs) (Table S7), while 46 CNVRs (18%) were located in
intergenic regions (Table S8). Gene containing CNVRs were also
predominant in individual chromosomes with the exception of
chr31 which was enriched with intergenic variants Fig. 2.
However, we consider calls for intergenic CNVRs tentative and
subject to change as the annotation of the horse genome is still in
progress.
Altogether, the CNVRs involved 805 protein-coding genes (750
Ensembl genes, 33 non-Ensembl genes and 22 horse mRNAs;
Table S7) but also non-coding small and long RNA genes, and
pseudogenes. The largest CNVRs with the highest number of
genes corresponded to clusters of olfactory and non-olfactory G-
protein coupled receptors (GPCRs) or to immunity related genes,
such as immunoglobulins, T-cell receptors, and MHC protein
complex genes - a typical feature of CNVRs in all mammalian
genomes studied so far [3,30,32,39,41,42]. Likewise, Gene
Ontology (GO) analysis indicated that equine copy number
variable genes are predominantly involved in biological processes
and molecular functions related to transmembrane signal trans-
duction, chemo-attractant sensory perception, immune response
and steroid metabolism (Fig. 3; Table S9). Notably, 5 copy
number variable genes from this study were associated with known
OMIA (http://omia.angis.org.au/home/) phenotypes for im-
mune, reproductive or neuromuscular diseases (Table 3), though
none of the OMIA records involved horses or CNVs. The CNVR
overlapping with the BMPR1B gene has been earlier reported in
horses and is of interest because of a possible role in the regulation
of the rate of ovulation [39].
Composite CNV dataset for the horse genome
Comprehensive knowledge of CNVs in normal horse popula-
tions, within and across breeds, is a prerequisite for the discovery
of variants that contribute to equine genetic diseases and disorders.
Therefore, we aligned the 258 CNVRs identified in this study with
previously published CNV data for the horse [35,36,37,38,39].
Altogether, we found records of about 2041 CNVs and CNVRs
(calling criteria vary between studies). These were further
consolidated, based on adjacent locations or partial overlaps, into
1476 CNVRs of which 301 CNVRs (20%) were shared between
two or more studies (Table S10, Fig. 4). The majority of shared
CNVRs involved genes associated with olfactory reception (50
CNVRs) and membrane transport (49 CNVRs) but also genes
involved in transcription (30 CNVRs), cell cycle regulation (12
CNVRs) and RNA genes (34 CNVRs). Expectedly, CNVRs that
were found in more than 100 horses and reported by all 6 studies
exclusively involved olfactory receptors. Comparative analysis also
revealed that novel (study-specific) CNVRs predominated over
shared ones in all 6 studies (Fig. 4). Novel CNVRs of functional
interest from this study involved genes related to sperm-egg
interaction and fertilization in chr4:19.8–19.9 Mb; a developmen-
tal gene SOX2 in chr19:20.1 Mb; an X-linked region harboring
genes of circadian pacemaker function chrX:83.8–84.0 Mb, and a
complex CNVR in chrUn:225–226 kb with cancer related genes.
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Notably, the latter two CNVRs were found in more than 10 horses
each. Details of all novel and shared CNVRs are presented in
Table S10.
Experimental validation of CNVRs by quantitative PCR
and FISH
Nineteen CNVRs were validated by quantitative PCR (qPCR)
using array probe-specific primers (Table S2). The regions were
selected upon three criteria – size, gene content and novelty. The
smallest tested CNVR was 4 kb and the largest 2 Mb; 13 involved
clusters of horse genes, and 6 were novel. A summary of qPCR
results are presented in Figure S3 and Table S11. All selected
CNVRs were first tested in the discovery horses and then analyzed
in more individuals of the same breed to identify possible breed-
specific tendencies. Overall, qPCR observations agreed well (P-
value,0.05) with the array CGH data for all discovery horses and
for other animals of the same breed. For example, it confirmed a
complex CNVR in chr27 involving CSMD1 gene (CUB and Sushi
multiple domains 1) which encodes a transmembrane and a
candidate tumor suppressor protein [43]. Copy numbers in this
region were tested on 11 breeds with at least 2 individuals each
and showed a gain in native ponies, draft breeds and the
Przewalski horse, and a loss in American Miniature horses in
relation to the Thoroughbred (Fig. 5A–B). Likewise, qPCR
confirmed a CNVR in chr20 (Fig. 5C) which has been found
only in this study and in indigenous plateau horses [38]. However,
we found some differences too between the two data sets: e.g.,
while qPCR confirmed a loss in chr20:32.0–32.4 Mb and
chr17:18.8–19.0 Mb in the discovery Swiss Warmblood and
Mongolian horses (Table S3), respectively, inclusion of additional
horses from the same breeds resulted in a significant gain in these
regions (Fig. S3). Also, initial qPCR confirmed a loss in chr7:74.8–
74.9 Mb in the two discovery Swiss Warmblood horses (Table S3)
but no significant losses were found when more individuals were
added. These minor discrepancies can be attributed to intra-breed
variation: array CGH was based on 2 to 4 individuals, while qPCR
involved 4 or more horses per breed (Figure S3, Table S11).
Two CNVRs, a complex 200 kb gain-loss region in chr1:114.0–
114.2 Mb and a 2.2 kb gain in chrUn: 529–531 kb) were
validated by FISH using CNV-containing CHORI-241 BAC
clones 132B13 (Fig. S4) and 91B23 (Fig. 6), respectively. Clear
differences in copy numbers between individual horses, as well as
between homologous chromosomes of the same horse were
observed. Additionally, the CNVR in chrUn was mapped to
horse chr19q12–q13 (Fig. 6).
Discovery of CNVs in horses with XY disorders of sexual
development (DSDs)
Finally, we carried out a pilot study to test the utility of the tiling
array and the integrated CNV data set (Table S10) for the
discovery of CNVs involved in equine XY disorders of sexual
development (XY DSD). Selection of the phenotype was based
upon studies in humans suggesting contribution of CNVs to XY
DSDs [25,27,28]. Array CGH experiments were carried out in 6
affected horses (Table 4): all had normal male 64,XY karyotype
with an intact SRY gene, abnormal male or female gonads, and
female or female-like external phenotype [44]. We determined 179
CNVs (average 30 calls per individual) and 107 CNVRs, of which
83 were common and shared with normal equine populations, and
24 CNVRs were novel (Table 5). Only 3 novel CNVRs were
shared between two or three XY DSD horses, while the remaining
21 were private and present in just one animal. Protein coding or
miRNA genes with functions in cell cycle regulation, transcription
and posttranscriptional processing were involved in 14 novel
CNVRs. None of the CNV-genes had known functions in sexual
differentiation or development.
Analysis of common CNVRs for highly aberrant log2 values
detected two likely homozygous deletions (Table 5): a 26 kb loss in
chr7 (log2 22.2) and a ,200 kb loss in chr29 (log2 23.5). The
latter was of particular interest because it was found in two closely
related American Standardbreds with very similar male-pseudo-
hermaphrodite phenotypes (H348 and H369; Table 4). The
CNVR was also present in 10 out of the 38 normal horses (Table
S3) including one American Standardbred, though with a
moderate aberration value (log2average 20.7) compared to
log2 =23.5 in the two XY DSD horses. Most notably, the CNVR
involved at least 4 members of the aldo-keto reductase AKR1C
gene family, known to be critical in the backdoor pathway of
dihydrotestosterone (DHT) synthesis and sexual development
[45,46]. A schematic overview of the CNVR, including the
involved genes and aberration profiles of all 47 array probes in the
region, is presented in Fig. 7. Homozygosity of the deletion was
confirmed by fluorescence in situ hybridization (FISH) with a
BAC clone (CHORI-241-23N13) spanning the deletion. The BAC
hybridized to chr29 in control animals but not in the two XY DSD
horses, whereas a control BAC (CHORI-241-76H613) with the
Figure 2. Chromosome-wise distribution of genic and intergenic CNVRs in the horse genome.
doi:10.1371/journal.pgen.1004712.g002
CNVs in Equine Health and Congenital Disorders
PLOS Genetics | www.plosgenetics.org 7 October 2014 | Volume 10 | Issue 10 | e1004712
CREM gene from a non-CNVR in chr29 [47] hybridized equally
in the XY DSD horses and controls (Fig. 7). Homozygosity of the
deletion was further confirmed by PCR showing that primers
designed inside the CNVR amplified genomic DNA of control
horses and the remaining 4 XY DSD horses, but not of the two
male-pseudohermaphrodite American Standardbreds (H348 and
H369; Fig. 7). Though primers designed outside the CNVR,
amplified the DNA by PCR in all horses – an evidence that the
DNA quality of the two Standardbreds was acceptable. We
theorized that the homozygous deletion involving AKR1C genes
in the two male-pseudohermaphrodite horses might be the risk
factor for abnormal sexual development.
Discussion
During just the past two years, five studies have addressed the
phenomenon of copy number variation in the horse genome
[35,36,37,38,39] contributing to our knowledge about the
genomic landscape of CNVs and their role in inter-individual
variation in horses. Despite the progress, lessons from humans
[48,49,50] and more recently from dogs [7,34], show that efficient
biomedical application of this information requires integration of
data from many more populations and individuals and the use of
comparable methodological platforms[48,49,50].
Here we report about the construction of a 400K high-density
WG tiling oligoarray for the horse and its application for the
discovery of CNVs in 38 normal horses of 16 diverse breeds, as
well as in 6 horses with congenital disorders. Probes on the array
were designed to detect CNVs in 18,763 equine autosomal and X-
linked genes but also in intergenic, sub-telomeric and Y
chromosome sequences. Regarding genome coverage, our CNV
discovery platform most closely resembled the recently reported
WG 1.3 M NimbleGen CGH array [38], but essentially comple-
mented the exon CGH array by Doan and colleagues [39] and the
studies based on WG SNP50 BeadChip [37,51]. The latter is of a
magnitude lower density and not specifically designed for CNV
capture. Also, as shown in humans and cattle, the efficiency of
CNV discovery is lower in SNP platforms compared to CNV
focused arrays [29,50]. While the future direction for CNV
research in any species is probably next generation sequencing
(NGS), the approach has as yet found only limited application in
horses: for the discovery of CNVs in the genome of a Quarter
Horse mare [35] and for the discovery of segmental duplications in
6 horse breeds and the donkey [52].
A unique feature of our CGH array was the inclusion of probes
from the Y chromosome and sub-telomeric regions. This was
because CNVs and segmental duplications are known to be an
integral part of the architecture of the mammalian Y chromosome
[53,54], while sub-telomeres are hotspots of DNA breakage and
repair, and undergo structural rearrangements more frequently
than the rest of the genome [40,55]. Despite the almost 6,000 sub-
telomeric probes with lower than average spacing (,4 kb vs.
,7 kb across the genome) on the array, only 10 CNVs were
detected in sub-telomeres and none in the Y chromosome
(Table 2). It is likely that the complex sub-telomeric sequences
are either missing or underrepresented in the current horse
sequence assembly [56], due to which it is possible that the probes
designed from the ends of the chromosomes, did not originate
from actual sub-telomeres.
Poor representation of centromeric/pericentromeric and telo-
meric/sub-telomeric sequences is a common shortcoming of all
draft genome assemblies. Whilst the horse may be different to
humans or other species in terms of subtelomeric sequences, this
can only be rigorously shown by sequencing BAC clones from
these regions, preferably with long-read single molecule technol-
ogy such as a Pacific Biosciences instrument to resolve long
repeats. Such an approach was recently successfully applied to
resolve regions of segmental duplications in the finished genome
sequence of humans [57].
The Y chromosome, on the other hand, has acquired and
amplified novel sequences, as well as sequences from the rest of the
genome [58]. Thus, it is likely that many potential copy number
variable Y probes did not pass the ‘uniqueness’ test by BLAST and
were dropped from the array (see Material and Methods for
details).
Integration and comparison of the CNV data for the
horse
The present and all previous CNV studies in horses
[35,36,37,38,39] differ by discovery platforms, genome coverage,
resolution, the study cohorts and analytical methods (Table 6).
Therefore, the overall numbers, size ranges and chromosomal
distribution of CNVs vary between the studies. For example, it has
been shown that due to analytical reasons, CGH-based studies
tend to detect more losses than gains [59]. This holds true for the
Agilent WG array in the present study and also the Nimblegen
WG array [38], though [38]slightly more gains were detected with
the Agilent exon array [39] (Table 6). The latter was attributed to
the large number of losses in the reference animal compared to the
Thoroughbred (Twilight) genome sequence assembly EquCab2
[56]. In contrast, gains vastly predominate (97%) among the
CNVs found by NGS in a Quarter Horse mare [35]. Apparent
Figure 3. Gene Ontology classifications of copy number variable genes in horses.
doi:10.1371/journal.pgen.1004712.g003
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differences in CNV calling algorithms and thresholds (Table 6),
on the other hand, are responsible for the variation in the
number of CNVs, their size and the criteria for merging
individual CNVs into CNVRs. For example, in this study we
mainly reported CNVRs because this is how the ADM-2
algorithm analyses and assembles the CNV calls (CNVs) within
and across individuals. Further, specific features of the probe/
array design, and not necessarily the number of probes, are
responsible for the differences in the genomic distribution of
discovered CNVs. So far, X-linked CNVs have been found only
in this study and by Doan & colleagues [39], and CNVs in chrUn
only in this study. Surprisingly, the study with a three times
denser 1.3 M Nimblegen array failed to detect CNVs in chrX, as
well as in [38] chrs30 and 31 [38]. At the same time, the latter
two small autosomes show the highest number of CNVs in the
Quarter Horse mare [35]. Major differences are also in the size,
diversity and origin of the study cohorts, ranging from just a few
breeds and individuals [35,38] to over 15 breeds (this study and
[37]) and hundreds of individuals [36,37] (Table 6).
Figure 4. A summary diagram of all CNV studies in horses and
their contribution to the integrated CNV dataset. Numbers in
arrow-heads denote the contribution of each study to the common
pool of 301 shared CNVRs; numbers in arrow-tails denote the total and
novel (separated by colon) CNVRs per study; CGH, SNP and NGS denote
the platforms used for CNV detection.
doi:10.1371/journal.pgen.1004712.g004
Figure 5. Validation of CNVRs by PCR. A. gains and B. losses in Chr27 (37.3 Mb; probe Gs_27_37371896) involving CUB and Sushi multiple
domains 1 (CSMD1) gene; C. Loss in Chr20 (24.8 Mb; probe Eic_20_24841849) involving olfactory receptors; n – number of individuals analyzed.
doi:10.1371/journal.pgen.1004712.g005
Figure 6. Chromosomal assignment and validation of a CNVR
in chrUn (529–531 kb) by FISH. A. Mapping the CNVR to chr19q12–
q13 by FISH with BAC 132B13 (red); green - a control BAC with UMPS
gene in chr19q21 [93]; B. The CNVR (red) in interphase chromosomes of
a Percheron; green – a single-copy control probe; C. The CNVR (red) in
interphase chromosomes of a Thoroughbred (Twilight). Note the
difference in copy numbers between the Percheron and the
Thoroughbred, as well as between homologous chromosomes.
doi:10.1371/journal.pgen.1004712.g006
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The many variables between the six studies (Table 6) obviously
confound assessments based solely on CNV metrics, and it would
probably be more appropriate to compare the actual CNVs/CNVRs
reported. Therefore, and in order to obtain a comprehensive overview
about the status of CNV discovery in horses, we integrated the CNVs
or CNVRs from all six studies ([35,36,37,38,39], this study) according
to their genomic locations into a composite dataset of 1476 CNVRs
(Table S10). Of these, 301 are reported by at least two studies, while
the remaining 1174 CNVRs are study-specific (novel; Fig. 4) and
require further validation.
The integrated dataset is a needed resource for evaluating new
CNV discoveries and gives an idea about the most intrinsic
Table 4. Horses with SRY-positive XY DSDs analyzed in this study.
Horse ID Breed Phenotype Karyotype SRY PCR Reference
H169 Appaloosa Normal external genitalia; hypoplastic uterus; underdeveloped
mammary glands; estrous behavior
64,XY pos [44]
H252 Mixed warmblood Small ventrally located vulva between rear legs; abnormally
small uterus
64,XY pos [44]
H348 Standardbred, Arizona Helen Female-like external phenotype; rudimentary abdominal
gonads (testes) - male pseudohermaphrodite
64,XY pos [44]
H369 Standardbred Martha Maxine Female-like external phenotype; rudimentary abdominal
gonads (testes) - male pseudohermaphrodite
64,XY pos [44]
H544 Tennessee Walking Horse Female-like external phenotype; rudimentary abdominal
gonads (testes) - male pseudohermaphrodite
64,XY pos This study
H546 Thoroughbred Female-like external phenotype; rudimentary abdominal
gonads (testes) - male pseudohermaphrodite
64,XY pos This study
doi:10.1371/journal.pgen.1004712.t004
Table 5. Novel and highly aberrant common (in bold font) CNVRs in XY DSD horses.
Horse ID Chr Start Stop Size, kb Gene symbol or sequence ID log2 average
H169 3 57,377,730 57,394,356 16.6 Intergenic 20.7
H546 4 95,018,254 95,034,834 16.5 ENSECAG00000014506 21.0
H369 8 13,128,936 13,134,708 5.7 MZT2B, TUBA3D 21.0
H544 10 51,078,681 51,119,659 40.9 Intergenic 20.9
H545 12 619,419 638,513 19.0 CSTF3 20.7
H544, H546 14 15,353,340 15,560,610 207.2 ENSECAG00000002162 20.7
H544 14 29,406,214 29,432,771 26.5 TET2 21.3
H369 15 14,237,934 14,272,519 34.5 BCL2L11 20.7
H544 15 44,348,596 44,377,735 29.1 eca-mir-217, eca-mir-216a, eca-mir-216b 21.1
H369 16 21,651,711 21,683,467 31.7 Intergenic 20.9
H546 16 65,654,753 65,661,154 6.4 Intergenic 21.1
H544 18 14,064,543 14,101,261 36.7 JU909423 21.0
H546 18 60,925,026 60,954,644 29.6 ENSECAG00000003850 21.2
H252 20 18,917,213 18,969,026 51.8 E2F3 +0.8
H546 20 36,503,850 36,508,477 4.6 SRSF3 21.0
H546 23 27,814,249 27,838,233 23.9 GLDC +0.8
H544 23 46,897,740 46,957,535 59.7 AK140548 20.9
H369 24 44,255,536 44,269,279 13.7 Intergenic 20.7
H544 25 22,614,255 22,768,706 154.4 JO239254 20.5
H544 26 5,796,076 5,840,516 44.4 TIGD1 21.2
H252 27 20,201,870 20,232,375 30.5 MICU3 20.5
H369, H544, H546 28 18,833,995 18,846,757 12.7 UBE2N 21.1
H252 X 203 366,729 366.5 AKAP17A, ASMT, ZBED1, XG 20.5
H544, H546 X 98,506,468 98,543,836 37.3 STAG2 21.1
H252 7 74,885,505 74,911,413 25.9 OR56B4 22.2
H348, H369 29 28,640,862 28,835,337 194.4 AKR1CL1, AKR1C2, AKR1C3, AKR1C4 23.5
doi:10.1371/journal.pgen.1004712.t005
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features of the CNV profile in horses. Copy number variants
account for about 1 to 3 % of the horse genome and there are
more CNVs that involve genes than those located in intergenic
regions. Though, the number of intergenic CNVs is possibly
deflated because all tiling arrays [38,39], including ours, have been
biased towards probes for gene exons. For example, 20% of the
probes in the Texas-Adelaide WG array represent protein coding
genes, whereas these genes make up only about 2–3% of the
mammalian genome. Notably, all studies find chr12 as the most
CNV-enriched (Table 6) and not because of many CNVs, but
because of a few very large clusters of olfactory receptors and
immunity-related genes (Tables S8, S10).
Copy number variants and segmental duplications
Studies in human [3,60], dogs [8] and cattle [30] have noted
strong correlation between CNVs and segmental duplications
(SDs). This is because SDs share 90% sequence similarity with
another genomic location and can promote CNV formation by
non-allelic homologous recombination [61]. Similar tendency has
been observed in horses [39], although horse SDs are relatively
small (largest ,60 kb) and comprise only about 0.5–0.6 % of the
genome [56], thus less than the portion involved in CNVs
(Table 6). Low level of SDs or low copy number repeats was also
reported by a recent de novo analysis of the equine genome where
no novel classes or types of interspersed repeats were identified
[62]. An additional 0.4% of SDs are in unplaced contigs (chrUn)
[56], though in this study only 0.04 % of chrUn sequences had
CNVs (Table 2). Likewise, chr25 which is the most SD-rich
chromosome (1.7%) according to EquCab2 genome assembly
[56], was only moderately enriched with CNVs (0.35%) in this
study. Yet, findings by us and others support the correlation
between CNVs and SDs in some genomic regions. For example, a
known large (750 kb) segmental duplication at the boundary of
ELA class I and class III [63] falls into a large common CNVR in
chr20:30,127,886–31,231,182 (Table S10); further, low copy
number directional repeats have been associated with large
deletions in the horse Y chromosome [44] or, GO categories,
such as olfactory reception and immune response, prevail among
the genes involved both in CNVs and SDs [52]. Therefore, for
improved understanding of the genomic architecture of CNVs and
their relation to genes and phenotypes in horses, it would be
worthwhile to focus future CNV research on associations between
CNVs and SDs, as recently successfully done in dogs [8].
Copy number variable genes and intergenic regions
It is noteworthy that regardless of the discovery methodology
and study cohorts, functional groups of genes that are most
affected by CNVs remain the same in all studies. These include
genes for transmembrane signal transduction and chemo-attrac-
tant sensory perception (olfactory and non-olfactory G-protein
coupled receptors, GPCRs), immune response (immunoglobulins,
T-cell receptors, MHC protein complexes), and steroid metabo-
lism (Table S9). Not coincidentally, CNVs are associated with the
same groups of genes in humans [3,64], cattle/ruminants
Figure 7. Schematic of the homozygous deletion in chr29, 28.6–28.8 Mb in two XY DSD horses. A. chr29 ideogram showing the location
of AKR1C genes and a control gene CREM; B. Detailed map of the CNVR showing the location of genes (black horizontal bars) and CGH signal log2
values for 47 array probes in XY DSD and control horses; C. FISH results with a BAC 23N13 spanning the deletion (green signal) and a control BAC
76H13 for CREM from a non-CNVR (red signal); D. PCR with CNVR-specific primers in XY DSD and control horses.
doi:10.1371/journal.pgen.1004712.g007
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[30,65,66], pigs [31], dogs [32] and even chicken [67], suggesting
the importance of inter-individual variation in these genes for
adaptive plasticity [68]. Indeed, genetic diversity and fine
functional tuning of sensory receptors, immunoglobulins, natural
killer and Toll-like receptors is further enhanced by additional
mechanisms, such as asynchronous replication which increases the
rate of tandem duplications, and monoallelic expression, so that
each sensory neuron or lymphoid cell expresses only one allele of a
gene [69,70]. Conserved linkage between distinct olfactory
receptor genes and the MHC in several mammalian species
suggests their concerted function - in this case, MHC-influenced
mate choice in reproduction [71]. Olfactory receptors are also
thought to function as chemo-sensing receptors to regulate sperm
density, motility, acrosome reaction and sperm-egg interaction in
fertilization [71,72]. Thus functionally, the CNV-enriched genes
in horses and other mammals fall into just three large categories:
sensory perception, immunity and reproduction.
Among the 258 CNVRs detected in this study, 20% were
located in intergenic regions. These CNVRs were relatively small
(average 50 kb, median 35 kb) and represented predominantly
losses (Fig. 2, Table S8). Prevalence of losses among intergenic
CNVRs has also been found in dogs [32]. Although there is no
information about possible implication of these regions on the
function of genes in animal genomes, studies in humans show that
intergenic deletions are significantly enriched among gene
expression-associated CNVs [73]. Thus, with the improvement
of genome sequence assembly and annotation in horses, intergenic
CNVRs will be of interest for future studies. We also anticipate
that as gene models are revised and converge more with the
underlying reality of the genes, some intergenic CNVRs may
become genic and vice versa.
Breed-specific CNVs
One of the goals of CNV research in horses is to find variants
that distinguish between breeds or groups of breeds and could be
associated with specific adaptations and phenotypic traits of
interest. In order to visualize the breeds and the degree of diversity
represented in this and previous studies, we performed a
phylogenetic analysis using population data of 15 microsatellite
loci [74] for the breeds involved (E.G. Cothran, unpublished). The
Table 6. Summary statistics of all CNV studies in horses.
This study Doan et al. 2012a
Doan et al.
2012b
Dupuis et al.
2012
Metzger et al.
2013 Wang et al. 2014
Platform Tiling array Tiling array n/a SNP Beadchip SNP Beadchip Tiling array
Production company Agilent Agilent n/a Illumina Illumina Nimblegen
Genome coverage WG Exons and UTRs WG WG WG WG
No of probes 400K 400K n/a 50K 50K 1.3 M
Method CGH CGH NGS SNP genotyping SNP genotyping CGH
Breeds 16 15 1 4** 17 6
Horses 38 16 1 477 717 6
CNV calling
algorithm
ADM-2 ADM-2 Control-FREE
copy number
(FREEC)
PennCNV [99] 1) CNVPartition
(Illumina); 2) PennCNV
[99]; 3) QuantiSNP [100]
segMNT
CNV calling
threshold
Log260.5, 5 probes Log260.5, 3 probes Breakpoint
at 20.0013;
a coefficient of
variation 0.045
PennCNV [99] *** Log260.5, 5 probes
No of CNVs per
animal
12 to 59 55 to 347 282 n/a Min 1, max n/a 22 to 84
No of CNVs/CNVRs* 258 775 282 478 166–1090 353
Gains 64 398 274 238 n/a 109
Losses 172 315 8 236 n/a 234
Complex 22 62 n/a n/a n/a n/a
CNV size range 1 kb–2.5 Mb 197 bp–3.5 Mb 3.7 kb–4.8 Mb 97 bp–2.7 Mb 516 bp–0.9 Mb** 6.1 kb–0.5 Mb
CNV size, mean, kb 110 5.3 n/a 114 487 38.5
CNV size,
median, kb
46 99.4 n/a 61 169 13.1
Genomic
distribution of CNVs
Autosomes, X, Un Autosomes, X Autosomes Autosomes Autosomes Autosomes, except
chr30, 31
Most enriched chr. 12 12 12 12 12 12
Chrs. with the
highest no. of CNVs
1; 20 1; 7 30; 31 1 12 20
Genome
enrichment %
1.15 3.65 3.53 2.32 1.7–22.0** 0.61
*As reported by original studies and before consolidating overlapping and tandemly located CNVRs into a composite dataset.
**Dupuis and colleagues specified only large groups of horses (warmblood, coldblood, draft, pony) but not individual breeds.
***Results by Metzger and colleagues vary between different analysis software packages used.
doi:10.1371/journal.pgen.1004712.t006
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dendrogram in Figure 8 shows that while the major clades of
domestic horses are represented, there is a clear preponderance of
the breeds with Thoroughbred ancestry. It is therefore noteworthy
that data for 11 new breeds, mainly representing native ponies and
draft horses, were added in this study. Nevertheless, the current
tally of horse breeds studied for CNVs is 41 (Table S12) which is
less than 10% of the over 400 horse breeds known worldwide [75].
Furthermore, given that just 7 breeds have been involved in 2 or
more studies (Fig. 8, Table S12) and several breeds are represent-
ed by one individual [38,39], any CNV reported to be breed-
specific should be taken with caution. For example, our composite
CNV dataset (Table S10) shows that the 18 CNVs reported to be
specific for Hanoverians [37] are present in other breeds. Likewise,
only one (chr13: 1,497,390.00–1,508,926.00; EIF2AK1) of the 7
plateau-breed-specific CNVs in heme binding genes [38] is not
found in other breeds. The same happened with our data where
initially we identified over 10 putative breed-specific CNVs which,
after comparison, reduced to 2 - one in Exmoor pony, another in
Swiss Warmblood horse (Table S4). Interestingly, no unique
CNVs were found in the Przewalski horse which shared similarity
mainly with ponies and draft breeds (Table S3). Besides, only 9 of
the 25 CNVs in Przewalski horses were shared between the two
individuals studied. Similar tendency for intra-breed individual
variation was observed for domestic horses where private CNVs
predominated over the shared ones. Nevertheless, as suggested by
other studies in horses [39], cattle [29], pigs [31] and dogs [33],we
anticipate that a small percentage of CNVs might remain unique
to their respective breeds, though this requires analysis of much
larger and more diverse equine populations. On the other hand,
most horse breeds are of recent origin with a good deal of cross-
breeding until closed breeds were established which has led to a
high degree of haplotype sharing [56,76], and thereby decreased
chances for finding breed-specific CNVRs compared to species
like dogs [34].
CNVs and disorders of sexual development
Probably the most exciting goal of CNV research in any species
is the discovery of pathogenic variants responsible for complex
diseases and congenital disorders. Among these, disorders of sexual
development (DSDs) are not uncommon in horses, though
causative mutations have been identified for just a few: Y
chromosome deletions in SRY-negative XY sex reversal mares
[44] and a point mutation in the androgen receptor gene in 3
related SRY-positive XY mares [77].
Here, we conducted the first pilot CNV analysis in horses with
XY DSD and identified a large autosomal (chr29) deletion in 2
related American Standardbreds (H348 and H369, Table 4). The
animals were classified as male pseudo-hermaphrodites with XY
male genotype, immature testes-like abdominal gonads, and
female-like external phenotype (Table 4). The deletion in
chr29:28.6–28.8 Mb was homozygous as confirmed by FISH
and PCR, and involved at least 8 genes of which 4 belonged to the
aldo-keto reductase family 1, member C (AKR1C; Fig. 7).
Annotation of these genes in the equine genome is, as yet,
preliminary and based on the alignment with human AKR1C
proteins in the UCSC Genome Browser (http://genome.ucsc.
edu/index.html) and mammalian homology in Ensembl (http://
www.ensembl.org/index.html). Therefore in Fig. 7, three genes
are denoted as AKR1CL1 and one gene has three labels,
corresponding to AKR1C2 in chimpanzee, AKR1C3 in human,
and AKR1C4 in cattle.
The AKR1C genes are members of the aldo-keto reductases
(AKR) superfamily [78]and encode for 3a-hydroxysteroid dehy-
drogenases [78] which are critically involved in steroid hormone
metabolism [79]. In the human genome, there are 4 family
members - AKR1C1, ALR1C2, AKR1C3 and AKR1C4, which
share 86% sequence identity and are clustered in HSA10p15-p14
[78,79]. The human AKR1C genes are not widely expressed:
AKR1C1 in brain, kidney, liver and testis, AKR1C2 in prostate
and brain, AKR1C3 in prostate and mammary gland, and
AKR1C4 in liver, whereas the rat has a single AKR1C gene
expressed in liver [79,80,81]. Among other functions, the AKR1C
genes are involved in the biochemical pathway that leads to
dihydrotestosterone (DHT) synthesis without testosterone inter-
mediate. As opposed to ‘classical’ DHT synthesis from cholesterol
and testosterone, this pathway is known as ‘the backdoor pathway’
and was originally discovered in marsupials [82] and thereafter in
eutherian mammals [45,46,83,84]. The importance of the
‘backdoor pathway’ and AKR1C genes in male sexual develop-
ment was recently demonstrated by a study in humans showing
that mutations in AKR1C2 and AKR1C4 genes cause abnormal
virilization and disordered sexual development, including XY sex
reversal [46,84]. Even though no mouse knockout models are
available for any of the AKR1C genes (MGI; http://www.
informatics.jax.org/), it is tempting to speculate that the homo-
zygous deletion in horse chr29 is a causative or a risk factor for
some forms of equine XY DSDs, such as male-pseudohermaph-
roditism, as observed in this study. It is also worth mentioning that
a CNV analysis of human XY DSDs detected a clinically
significant de novo 64 kb duplication in HSA10p14 [28] - a
genomic segment next to the AKR1C gene cluster (UCSC: http://
genome.ucsc.edu/cgi-bin/hgGateway). Whether this is a coinci-
Figure 8. Genetic relationships of horse breeds studied for
CNVs. A Maximum Likelihood tree showing genetic relationships of the
horse breeds that have been studied for CNVs; * new breeds added in
this study (except Swiss Warmblood);** breeds involved in 2 or more
studies. Numbers denote bootstrap values.
doi:10.1371/journal.pgen.1004712.g008
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dence or the region includes more copy number variable factors
contributing to DSDs, needs further investigation. [45,46,84] [84]
[28].
Our findings in horses might be of even broader interest
because the two deletion carrying horses were elite American
Standardbred pacers, Martha Maxine and Arizona Helen
(Table 4), whose problematic sexual identity has become public,
making headlines in The New York Times [85] and The Horse [86].
Thus, studies are underway to precisely determine the deletion
breakpoints and develop molecular tests for detecting other horses
with a similar deletion, as well as heterozygous carriers. Finally,
the fact that only 2 XY DSD horses out of 6 had this mutation
underscores the phenotypic and genetic heterogeneity of these
disorders.
Concluding statement
This study represents an important contribution to CNV research
in horses by identifying new CNVs and developing an integrated
datset of 1476 CNVRs to facilitate the discovery of variants of
biomedical importance. However, despite progress, the majority of
the CNVRs reported for the horse require proper validation by
methodologically comparable studies invloving more diverse breeds
and individual animals. Last but not least, due to the very nature of
CNVs, these regions are likely to have sequence assemblies not as
accurate as non-variable regions. Thus, the findings also identified
potential targets for genome re-sequencing and -assembly.
Materials and Methods
Ethics statement
Procurement of peripheral blood and hair was performed
according to the United States Government Principles for the
Utilization and Care of Vertebrate Animals Used in Testing,
Research and Training. These protocols were approved by Texas
A&M Office of Research Compliance and Biosafety as AUP2009-
115, AUP2012-0250. CRRC09-32 and CRRC09-47.
Array design
A horse WG tiling array was designed using the horse genome
draft sequence (EquCab2, http://www.ncbi.nlm.nih.gov/
assembly/286598; [56], Oligowiz2.0 (http://www.cbs. dtu.dk/
services/OligoWiz/), ArrayOligoSelector (http://arrayoligosel.
sourceforge.net/), and ArrayDesign [87] software packages. The
array comprised 417,377 60-mer oligonucleotide probes: 85,852
probes corresponded to one or more exons of the 18,763
annotated equine genes (http://www.ncbi.nlm.nih.gov/genome/
genomes/145?); 305,416 probes originated from intergenic regions
(excluding sub-telomeres); 5,716 probes were designed from sub-
telomeres (the terminal 1 Mb of each chromosome), and 519
probes represented the horse Y chromosome [58]; our unpub-
lished data). [87]For intergenic probes, including chrUn, repeat-
masked (http://www.repeatmasker.org/) sequences were used.
For reference genes, we first designed probes from exons. If these
were not specific, attempts were made to design probes from
introns and upstream/downstream flanking regions of those genes.
Before inclusion in the array, the specificity of all sequences were
analysed with BLAT (http://www.kentinformatics.com/) and
BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the Equ-
Cab2 reference genome sequence. Probes with more than one hit
in the genome were discarded. Possible cross-hybridization of the
probes was further evaluated using Kane’s parameters [88] and all
probes that had a total percent identity .75–80% with a non-
target sequence, or probes with contiguous stretches of identity .
15 nucleotides with a non-target sequence were discarded. Only
probes with high specificity were kept in the final array. A
Cytoband file was generated to align the horse draft sequence
assembly with the cytogenetic map [89]. The array, designated as
the Texas-Adelaide horse WG tiling array, was fabricated by
Agilent Technologies using Agilent SurePrint G3 technology and
26400K chip format (two arrays on a single slide). The array is
available at Agilent Technologies; Design ID #030025, Cat. No
G4124A.
Horses, breeds, phenotypes
The CNV discovery cohort comprised 38 horses representing
16 diverse breeds and the Przewalski’s horse (Table S1). Horse
breeds were selected according to the recent population studies
[51,56,76,90] with an aim to maximize the genetic diversity
among samples and to encompass the common warm blood, cold
blood (draft) and native pony breeds. An additional cohort of 52
normal horses representing the same 16 breeds was used for
quantitative PCR validation of CNVs. Finally, a pilot study testing
the utility of the tiling array for the discovery of CNVs
contributing to equine congenital disorders used 6 horses
previously diagnosed with XY disorders of sexual development
(XY DSDs; Table 4) [44].
DNA isolation
Genomic DNA was isolated from peripheral blood or hair
follicles using QIAGEN Gentra PureGene Blood kit (Qiagen)
according to manufacturer’s protocol. The DNA was cleaned with
DNeasy Blood and Tissue kit (Qiagen) and quality checked by gel
electrophoresis and by Nanodrop spectrophotometry (Thermo
Scientific).
Array comparative genomic hybridization
Probe labeling and array CGH experiments were performed
according to Agilent Technologies Protocol Version 7.3, March
2014 (http://www.chem.agilent.com/Library/usermanuals/
Public/G4410-90010_CGH_Enzymatic_7.3.pdf). All hybridiza-
tions comprised of a pair of differently labeled probes, one of
which was always the reference DNA – a Thoroughbred mare
Twilight for females and a Thoroughbred stallion Bravo for males
(see explanations below). The genomic DNA (gDNA) was cleaved
to 200–500 bp fragments with RsaI and AluI (Promega) and
labeled with Cy3 (the reference DNA) or Cy5 (sample DNA) by
random priming using Genomic DNA Enzymatic Labeling Kit
(Agilent Technologies). The products were cleaned with 30 kDa
filters (Amicon) and the yield and specific activity of labeled DNA
was determined with a Nanodrop spectrophotometer. Typical
yield for 1 mg of starting DNA was 6–8 mg; specific activity for Cy3
was 25–40 pmol/mg and for Cy5 20–35 pmol/mg. The hybrid-
ization mixture was prepared using Agilent Oligo aCGH
Hybridization Kit and contained equal quantity of Cy3 and Cy5
labeled probes, 1 mg/mL horse Cot1 DNA, 106 blocking agent,
and 26 Hi-RPM buffer. Denatured and pre-annealed probe
mixture was applied onto gasket slide, placed in Agilent SureHyb
hybridization chamber, ‘sandwiched’ with an array slide and
incubated in Agilent hybridization oven at 65uC for 40 hours. The
array slides were washed with Agilent aCGH Wash Buffers 1 and
2 and dried with Acetonitrile and Stabilization and Drying
Solutions (Agilent Technologies).
Array CGH data analysis
The slides were scanned with Agilent SureScan DNA Micro-
array Scanner and Scanner Control software v8.3. The data were
extracted and normalized with Agilent Feature Extraction
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software v10.10.1.1 and saved in.fep format. The Feature
Extraction software also checks the quality of aCGH by measuring
Derivative Log2 Ratio Standard Deviation (DLRSD), Signal-To-
Noise Ratio (SNR) and Background Noise (BGNoise). The data
were analyzed with Agilent Genomic Workbench 5.0 software. In
each array spot log2 ratios of Cy3 versus Cy5 were computed with
the default P-value threshold 0.05 and overlap threshold value 0.9.
The CNVs were represented by gains and losses of normalized
fluorescence intensities relative to the reference and called by
conservative criteria which required alterations of .0.5 log2 ratios
over 5 neighboring probes. Homozygous losses were called when
signal log2 ratio was ,22.0. Copy number variable regions
(CNVRs) were determined by ADM-2 algorithm [91] by
combining overlapping and adjacent CNVs in all samples across
the CGH experiments. Output files were generated with genomic
coordinates and cytoband locations for all CNVs. The raw data
were submitted to NCBI Gene Expression Omnibus (GEO)
accession GSE55266.
Array performance evaluation
To evaluate baseline variations and determine FDR [92,93]
female and male self-to-self, and female-to-male control hybrid-
izations were conducted using blood DNA from one female and
one male Thoroughbred horses. The female Thoroughbred,
Twilight, was the DNA donor for the horse reference sequence
EquCab2 [56] and the origin of the probes on the tiling array. The
male Thoroughbred, Bravo, a half-sibling to Twilight, was the
DNA donor for the CHORI-241 BAC library (http://bacpac.
chori.org/equine241.htm) and the origin of all Y chromosome
probes on the array. The FDR was calculated as a percentage of
the ratio of CNVs in self-to-self hybridization to the total number
of CNVs in all experiments. Additionally, array performance was
evaluated by self-to-self hybridizations with blood and hair DNA
from one Quarter Horse (H528, Table S1). Hybridization quality
was assessed by DLRSD which calculates probe-to probe log ratio
noise of an array; (http://www.chem.agilent.com/Library/
applications/5989-6624EN.pdf): DLRSD ,0.2 was considered
excellent; 0.2$DLRSD#0.3 was good, and values .0.3 indicated
poor quality hybridization.
Chromosome CNVR enrichment
Horse chromosome enrichment percentage was determined by
the total length of CNVRs present in each chromosome, divided
by chromosome length (Ensembl, http://www.ensembl.org/
index.html).
Gene ontology enrichment analysis
Ensembl gene list (Ensembl Genebuild 73.2) along with their
position in the horse genome was added to Agilent Genomic
Workbench as a custom track to determine the genic and
intergenic CNVs. Gene Ontology analysis (GO) and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway analysis
of the genes present in CNVs were performed using DAVID
bioinformatics tool with default settings [94,95]. Because only a
limited number of genes in the horse genome have been
annotated, horse gene IDs were converted to orthologous human
Ensembl gene IDs by BioMart, followed by GO and pathway
analyses, as described above. Biological functions of the genes in
CNVRs were further analyzed manually by data mining in
Ensembl (http://www.ensembl.org/index.html), UCSC (http://
genome.ucsc.edu/) and NCBI (http://www.ncbi.nlm.nih.gov/)
Genome Browsers searching for data for equine orthologs in
other mammalian species. CNVs present in intergenic regions
were analyzed in UCSC genome browser and NCBI and
GeneCards (http://www.genecards.org/) for similarities to known
mammalian genes.
A composite CNV dataset for the horse (Table S10) was
generated by aligning genomic positions of CNVs/CNVRs from
this and all previously published studies [35,36,37,38,39]. Partially
or completely overlapping and adjacent CNVs (the end position of
a previous CNV and the start position of the next CNV are the
same) were consolidated into one CNVR.
Array CGH data validation by qualitative and quantitative
PCR
Genomic copy number changes as detected by aCGH were
validated by quantitative PCR (qPCR) for 18 selected CNVRs
using 22 probe-specific primers. Additionally, 8 putative
homozygous deletions were validated by regular (qualitative)
PCR. Primers (Table S2) were designed inside CNVRs using
array probe sequences and the horse whole genome sequence
information (EquCab2 at UCSC: http://genome.ucsc.edu/and
Ensembl: http://www.ensembl.org/index.html) and Primer3
software (http://bioinfo.ut.ee/primer3-0.4.0/primer3/input.
htm). The qPCR experiments were performed with LightCycler
480 (Roche Diagnostics) in triplicate assays. Each assay was
done in triplicate 20 mL reactions containing 50 ng of template
DNA, 10 mM primers and the SYBR Green PCR kit (Roche).
Relative copy numbers of the selected regions were determined
in comparison to the reference sample (Thoroughbred and
Quarter Horse) and normalized to an autosomal reference gene
GAPDH. The cycling conditions were 1 cycle 5 min at 95uC; 45
cycles 10 sec at 95uC, 5 sec at 58uC, and 10 sec at 72uC; 1 cycle
for melting curve 30 sec 95uC, 30 sec 65uC and final cooling
20 sec at 50uC. Quantification of the copy number was carried
out using the comparative CT method (2
DDCt) [96,97] with p,
0.05 as a cut-off threshold for statistical significance. Qualitative
PCR results were analyzed by agarose gel electrophoresis.
Array CGH data validation by fluorescence in situ
hybridization (FISH)
CNV specific primers were used to screen CHORI-241 BAC
library (http://bacpac.chori.org/equine241.htm) by PCR (Table
S2); BAC DNA was isolated by Plasmid Midiprep kit (Qiagen),
labeled with biotin-16-dUTP or digoxigenin-11-dUTP using
Biotin- or DIG-Nick Translation Mix (Roche), and hybridized to
metaphase chromosomes of CNV carriers and control horses
following standard protocols [98]. A BAC clone representing a
non-CNV region was used as a control in each FISH experiment.
Images for a minimum of 20 metaphase and/or interphase cells
were captured for each experiment and analyzed with a Zeiss
Axioplan2 fluorescent microscope equipped with Isis v5.2
(MetaSystems GmbH) software.
Phylogenetic analysis
Genotypes for 15 microsatellite loci [74]; E.G. Cothran,
unpublished) were available for 32 out of 41 horse breeds involved
in CNV studies (see Table S12). Majority-rule consensus of
Restricted Maximum Likelihood (RML) trees were constructed
and visualized as described elsewhere [74]. The Przewalski Horse
population was used as an out-group.
Supporting Information
Figure S1 Array and aCGH quality control. A. Genome-wide
distribution of CNVs in self-to-self hybridization (upper) compared
to cumulative hybridizations with all animals (lower) to determine
FDR; green vertical lines denote CNVs; B. Male-to-female aCGH
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results for the X chromosome; C. DLRSD values of aCGH using
DNA from blood (left) and from hair (right) of the same individual.
(PDF)
Figure S2 Homozygous deletions. Confirmation of putative
homozygous deletion CNVs (red arrows) by qualitative PCR.
(PDF)
Figure S3 Validation of selected CNVRs by quantitative PCR
(qPCR). A1–A14 qPCR was in agreement with aCGH in
discovery horses and their breed-mates; B1–B3 qPCR agrees
with aCGH in the discovery horse (left) but not in additional
horses of the same breed (right).
(PDF)
Figure S4 Validation of a copy number gain in chr1 (114.0 Mb)
by FISH. A. and B. – metaphase and interphase of the
Thoroughbred control; C. and D. metaphase and interphase of
a Quarter Horse; red signals - BAC 132B13; green signals in D. –
a single-copy control BAC. Note the difference in copy numbers
between homologous chromosomes in both horses.
(PDF)
Table S1 Horse breeds (n = 16) and individuals (n = 38) used in
this study.
(XLSX)
Table S2 Primers for quantitative and qualitative PCR to
validate CNVs.
(XLSX)
Table S3 List of all 950 CNV calls in the study cohort.
(XLSX)
Table S4 Tentative breed-specific CNVRs.
(XLSX)
Table S5 258 CNVRs identified in the horse genome in this
study.
(XLSX)
Table S6 Gains and losses with high log2 alteration values.
(XLSX)
Table S7 Genomic locations, names, symbols and known or
predicted functions of copy number variable genes.
(XLSX)
Table S8 Intergenic CNVRs.
(XLSX)
Table S9 GO analysis of equine copy number variable genes.
(XLSX)
Table S10 Integrated dataset of 1476 CNVs/CNVRs in the
horse.
(XLSX)
Table S11 Details of validation of 19 selected CNVRs by qPCR.
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Table S12 List of horse breeds studied for CNVs.
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